Blog
RSS FeedPosted by Michael Wonder on 21 Jul 2022
TGA approves Padcev
21 July 2022 - Enfortumab vedotin is an antibody-drug conjugate targeting nectin-4, an adhesion protein located on the surface of epithelial ...
Posted by Michael Wonder on 19 Jul 2022
ATAGI update following weekly COVID-19 meeting (13 July 2022)
19 July 2022 - On Wednesday 13 July 2022, ATAGI met to consider the latest developments relating to COVID-19 immunisation. ...
Posted by Michael Wonder on 19 Jul 2022
TGA provisionally approves Moderna COVID-19 vaccine (Spikevax) for use in children from 6 months
19 July 2022 - The TGA has provisionally approved a paediatric dose of the Moderna COVID-19 vaccine, Spikevax, for use ...
Posted by Michael Wonder on 18 Jul 2022
Aussies could get omicron targeted jab earlier than most
18 July 2022 - Australia could become one of the first countries in the world to administer an omicron-specific vaccine, ...
Posted by Michael Wonder on 15 Jul 2022
TGA approves Grifols' Xembify
15 July 2022 - Xembify is yet another presentation of human immunoglobulin. ...
Posted by Michael Wonder on 14 Jul 2022
COVID-19 vaccine safety report (14 July 2022)
14 July 2022 - To 10 July 2022, the TGA has received 609 reports which have been assessed as likely to ...
Posted by Michael Wonder on 07 Jul 2022
ATAGI updated recommendations for a winter dose of COVID-19 vaccine
7 July 2022 - ATAGI has updated its recommendations for a winter dose of COVID-19 vaccine to help reduce severe ...
Posted by Michael Wonder on 06 Jul 2022
Australian Technical Advisory Group on Immunisation makes call on fourth Covid vaccine dose
6 July 2022 - Australians as young as 30 will be eligible to get a fourth dose of the Covid jab ...
Posted by Michael Wonder on 06 Jul 2022
TGA grants provisional determinations to Pfizer for COVID-19 vaccines to target Omicron variant
6 July 2022 - On 5 July 2022, the TGA granted two provisional determinations to Pfizer in relation to COVID-19 ...
Posted by Michael Wonder on 05 Jul 2022
ATAGI update following weekly COVID-19 meeting (29 June 2022)
5 July 2022 - An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 29 ...
Posted by Michael Wonder on 04 Jul 2022
Report on 'Cell, Gene and Tissue Regulatory Framework in Australia: Stakeholder Perspectives' - TGA response
4 July 2022 - n November 2021 the TGA commissioned MTP Connect to conduct a stakeholder review of the regulatory ...
Posted by Michael Wonder on 01 Jul 2022
COVID-19 vaccine safety report (30 June 2022)
30 June 2022 - The Australian Government has decided the COVID-19 vaccine safety report will now be published fortnightly instead of ...
Posted by Michael Wonder on 30 Jun 2022
Review into COVID-19 vaccine and treatment purchases
30 June 2022 - The Australian Government is undertaking an independent review of Australia’s vaccine and treatment procurements, led by former ...
Posted by Michael Wonder on 30 Jun 2022
Provisional determination granted to Pfizer in relation to COVID 19 vaccine (Comirnaty) - for use in individuals 6 months up to 5 years
30 June 2022 - On 28 June 2022, the TGA granted a provisional determination to Pfizer Australia in relation to ...
Posted by Michael Wonder on 28 Jun 2022
Fees and charges: summary from 1 July 2022
27 June 2022 - The TGA has updated its summary of fees and charges effective 1 July 2022. ...